Patent directory · USPTO A61K / A61P
Patents matching “Aligos Therapeutics, Inc.”
32 pharma patents match "Aligos Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 32 pharmaceutical patents matching "Aligos Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12384779
Bicyclic compounds
granted -
US 12252481
Anti-viral compounds
granted -
US 12180192
Modulators of THR-β and methods of use thereof
granted -
US 12129469
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted -
US 12065428
Anti-viral compounds
granted -
US 12018015
Methods and compositions for targeting PD-L1
granted -
US 11957683
Bicyclic compounds
granted -
US 11952374
Bicyclic compounds
granted -
US 11952365
Anti-viral compounds
granted -
US 11939581
Methods and compositions for targeting PD-L1
granted -
US 11858913
Bicyclic pyridazinones and methods of use thereof
granted -
US 11851422
Anti-viral compounds
granted -
US 11845752
Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B
granted -
US 11840532
Modulators of THR-β and methods of use thereof
granted -
US 11820773
Tricyclic compounds
granted -
US 11793815
Oxindoles and methods of use thereof
granted -
US 11786532
2-pyridones and methods of use thereof
granted -
US 11787833
Modified cyclic dinucleoside compounds as sting modulators
granted -
US 11771680
Pyrrole compounds
granted -
US 11760761
Methods and compositions for targeting PD-L1
granted -
US 11760764
Methods and compositions for targeting PD-L1
granted -
US 11613750
Methods of reducing virus molecule levels
granted -
US 11591341
Bicyclic and tricyclic compounds
granted -
US 11549110
Modified short interfering nucleic acid (siNA) molecules and uses thereof
granted